Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The delay to close the last PP.

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Nov 08, 2022 10:48am

342 Views

Post# 35081936

RE:The delay to close the last PP.

As others have said I suspect that they didn't appreciate how little is known about this company and how all the long holders are likely at target holdings. Simply no more buyers out there without some big pr push or catalyst.

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch